Experimental infection of infant rabbits with verotoxin-producing Escherichia coli.

PubWeight™: 2.64‹?› | Rank: Top 1%

🔗 View Article (PMC 261059)

Published in Infect Immun on January 01, 1986

Authors

C H Pai, J K Kelly, G L Meyers

Articles citing this

Diarrheagenic Escherichia coli. Clin Microbiol Rev (1998) 30.09

Infection by verocytotoxin-producing Escherichia coli. Clin Microbiol Rev (1989) 16.53

Shiga and Shiga-like toxins. Microbiol Rev (1987) 8.58

Role of a 60-megadalton plasmid and Shiga-like toxins in the pathogenesis of infection caused by enterohemorrhagic Escherichia coli O157:H7 in gnotobiotic piglets. Infect Immun (1987) 3.96

A plasmid of enterohemorrhagic Escherichia coli O157:H7 is required for expression of a new fimbrial antigen and for adhesion to epithelial cells. Infect Immun (1987) 3.76

Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion. Microbiol Rev (1996) 3.46

Attaching and effacing locus of a Citrobacter freundii biotype that causes transmissible murine colonic hyperplasia. Infect Immun (1993) 3.34

Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II. Infect Immun (1990) 3.02

Characterization of Escherichia coli serotype O157:H7. J Clin Microbiol (1988) 3.01

Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7. Infect Immun (1990) 3.00

Enterohemorrhagic Escherichia coli O157:H7 requires intimin to colonize the gnotobiotic pig intestine and to adhere to HEp-2 cells. Infect Immun (1995) 2.69

Surface properties of the Vero cytotoxin-producing Escherichia coli O157:H7. Infect Immun (1987) 2.34

Experimental verocytotoxemia in rabbits. Infect Immun (1992) 1.94

Enterohaemorrhagic Escherichia coli O157:H7 target Peyer's patches in humans and cause attaching/effacing lesions in both human and bovine intestine. Gut (2000) 1.92

Diarrheal disease caused by enterotoxigenic Bacteroides fragilis in infant rabbits. J Clin Microbiol (1989) 1.90

Natural and experimental infection with an attaching and effacing strain of Escherichia coli in calves. Infect Immun (1986) 1.87

Attaching and effacing adherence of Vero cytotoxin-producing Escherichia coli to rabbit intestinal epithelium in vivo. Infect Immun (1988) 1.85

Critical roles for stx2, eae, and tir in enterohemorrhagic Escherichia coli-induced diarrhea and intestinal inflammation in infant rabbits. Infect Immun (2003) 1.81

Morphologic evaluation of the effects of Shiga toxin and E coli Shiga-like toxin on the rabbit intestine. Am J Pathol (1986) 1.72

Shiga toxins induce, superinduce, and stabilize a variety of C-X-C chemokine mRNAs in intestinal epithelial cells, resulting in increased chemokine expression. Infect Immun (2001) 1.69

Association of enterohemorrhagic Escherichia coli hemolysin with serotypes of shiga-like-toxin-producing Escherichia coli of human and bovine origins. Appl Environ Microbiol (1998) 1.55

Edema disease-like brain lesions in gnotobiotic piglets infected with Escherichia coli serotype O157:H7. Infect Immun (1989) 1.47

Alteration of the carbohydrate binding specificity of verotoxins from Gal alpha 1-4Gal to GalNAc beta 1-3Gal alpha 1-4Gal and vice versa by site-directed mutagenesis of the binding subunit. Proc Natl Acad Sci U S A (1992) 1.43

Virulence of an Escherichia coli O157:H7 sorbitol-positive mutant. Appl Environ Microbiol (1993) 1.40

Shiga Toxin (Stx) Type 1a Reduces the Oral Toxicity of Stx Type 2a. J Infect Dis (2016) 1.39

Cattle lack vascular receptors for Escherichia coli O157:H7 Shiga toxins. Proc Natl Acad Sci U S A (2000) 1.38

Apoptosis of renal cortical cells in the hemolytic-uremic syndrome: in vivo and in vitro studies. Infect Immun (1998) 1.27

Protective effect of Lactobacillus casei strain Shirota on Shiga toxin-producing Escherichia coli O157:H7 infection in infant rabbits. Infect Immun (2001) 1.23

The locus of enterocyte effacement-encoded effector proteins all promote enterohemorrhagic Escherichia coli pathogenicity in infant rabbits. Infect Immun (2005) 1.19

stx1c Is the most common Shiga toxin 1 subtype among Shiga toxin-producing Escherichia coli isolates from sheep but not among isolates from cattle. J Clin Microbiol (2003) 1.13

Effect of Chlamydia trachomatis infection and subsequent tumor necrosis factor alpha secretion on apoptosis in the murine genital tract. Infect Immun (2000) 1.12

Interaction of verotoxin 2e with pig intestine. Infect Immun (1996) 1.08

Enterohemorrhagic E. coli alters murine intestinal epithelial tight junction protein expression and barrier function in a Shiga toxin independent manner. Lab Invest (2010) 1.06

Role of tumor necrosis factor alpha in gnotobiotic mice infected with an Escherichia coli O157:H7 strain. Infect Immun (1998) 1.04

Pathogenic mechanism of mouse brain damage caused by oral infection with Shiga toxin-producing Escherichia coli O157:H7. Infect Immun (2000) 1.02

Relationship of genetic type of Shiga toxin to manifestation of bloody diarrhea due to enterohemorrhagic Escherichia coli serogroup O157 isolates in Osaka City, Japan. J Clin Microbiol (2000) 1.00

Shiga Toxin (Stx) Classification, Structure, and Function. Microbiol Spectr (2014) 0.99

Human intestinal tissue and cultured colonic cells contain globotriaosylceramide synthase mRNA and the alternate Shiga toxin receptor globotetraosylceramide. Infect Immun (2010) 0.96

Shiga toxin-producing Escherichia coli can impair T84 cell structure and function without inducing attaching/effacing lesions. Infect Immun (1999) 0.94

Oral intoxication of mice with Shiga toxin type 2a (Stx2a) and protection by anti-Stx2a monoclonal antibody 11E10. Infect Immun (2013) 0.93

Purification and characterization of Shiga toxin 2f, an immunologically unrelated subtype of Shiga toxin 2. PLoS One (2013) 0.90

Enhanced Actin Pedestal Formation by Enterohemorrhagic Escherichia coli O157:H7 Adapted to the Mammalian Host. Front Microbiol (2011) 0.90

Shiga toxin in enterohemorrhagic E.coli: regulation and novel anti-virulence strategies. Front Cell Infect Microbiol (2012) 0.90

Development of monoclonal antibodies and immunoassays for sensitive and specific detection of Shiga toxin Stx2f. PLoS One (2013) 0.88

Intimin, tir, and shiga toxin 1 do not influence enteropathogenic responses to shiga toxin-producing Escherichia coli in bovine ligated intestinal loops. Infect Immun (2002) 0.87

Efficient colonization of the bean bug Riptortus pedestris by an environmentally transmitted Burkholderia symbiont. Appl Environ Microbiol (2013) 0.86

Escherichia coli O157:H7 infection in Dutch belted and New Zealand white rabbits. Comp Med (2010) 0.82

Effect of Shiga toxin 2 on water and ion transport in human colon in vitro. Dig Dis Sci (2000) 0.81

Intestinal damage in enterohemorrhagic Escherichia coli infection. Pediatr Nephrol (2010) 0.81

Hemorrhagic gastroenteritis caused by Escherichia coli in piglets: Clinical, pathological and microbiological findings. Can Vet J (1992) 0.79

Shiga toxin-associated hemolytic uremic syndrome complicated by intestinal perforation in a child with typical hemolytic uremic syndrome. Korean J Pediatr (2014) 0.75

Articles cited by this

Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer (1972) 35.74

Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med (1983) 25.72

The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis (1985) 16.43

Vero response to a cytotoxin of Escherichia coli. Infect Immun (1977) 13.49

Role of the K88 antigen in the pathogenesis of neonatal diarrhea caused by Escherichia coli in piglets. Infect Immun (1972) 11.29

Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype. J Clin Microbiol (1983) 10.23

Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet (1983) 10.11

A clinicopathologic study of enterocyte-adherent Escherichia coli: a cause of protracted diarrhea in infants. Gastroenterology (1982) 8.38

Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli. J Infect Dis (1982) 8.05

Pathogenesis of escherichia coli gastroenteritis in man--another mechanism. N Engl J Med (1980) 8.01

Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea. Science (1984) 7.94

Plasmid-mediated adhesion in enteropathogenic Escherichia coli. J Pediatr Gastroenterol Nutr (1983) 6.59

Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Clinical, epidemiologic, and bacteriologic features. Ann Intern Med (1984) 6.54

Detection and characterization of colonization factor of enterotoxigenic Escherichia coli isolated from adults with diarrhea. Infect Immun (1978) 5.71

Histologic fixatives suitable for diagnostic light and electron microscopy. Arch Pathol Lab Med (1976) 5.37

Shigellosis due to Shigella dysenteriae. 1. Relative importance of mucosal invasion versus toxin production in pathogenesis. J Infect Dis (1972) 4.60

Vero cell toxins in Escherichia coli and related bacteria: transfer by phage and conjugation and toxic action in laboratory animals, chickens and pigs. J Gen Microbiol (1983) 4.52

Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Ann Intern Med (1984) 3.88

Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli. Infect Immun (1983) 3.85

Pathogenesis of Shigella dysenteriae 1 (Shiga) dysentery. J Infect Dis (1973) 3.45

Chronic diarrhea in infants caused by adherent enteropathogenic Escherichia coli. J Pediatr (1982) 3.33

Colonization of chicken cecae by Escherichia coli associated with hemorrhagic colitis. Appl Environ Microbiol (1985) 3.18

Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes. N Engl J Med (1978) 2.95

Extreme sensitivity of some intestinal crypt cells to X and gamma irradiation. Nature (1977) 2.82

The response of man to virulent Shigella flexneri 2a. J Infect Dis (1969) 1.97

An electron-microscope study of the mode of cell death induced by cancer-chemotherapeutic agents in populations of proliferating normal and neoplastic cells. J Pathol (1975) 1.83

The neurotoxin of Shigella shigae; a comparative study of the effects produced in various laboratory animals. Br J Exp Pathol (1956) 1.57

Haemolytic-uraemic syndrome complicating shigella dystentery in south Indian children. Br Med J (1978) 1.56

Cellular serine proteinase induces chemotaxis by complement activation. Nature (1977) 0.92

Articles by these authors

Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Clinical, epidemiologic, and bacteriologic features. Ann Intern Med (1984) 6.54

Production of enterotoxin by Yersinia enterocolitica. Infect Immun (1978) 3.94

Campylobacter gastroenteritis in children. J Pediatr (1979) 3.42

Serum resistance associated with virulence in Yersinia enterocolitica. Infect Immun (1982) 3.37

Detection of Salmonella typhi in the blood of patients with typhoid fever by polymerase chain reaction. J Clin Microbiol (1993) 3.08

Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study. Clin Infect Dis (1999) 2.74

Yersinia enterocolitica gastroenteritis: a prospective study of clinical, bacteriologic, and epidemiologic features. J Pediatr (1980) 2.73

Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis. J Clin Microbiol (1987) 2.59

Plasmid-mediated resistance to phagocytosis in Yersinia enterocolitica. Infect Immun (1987) 2.43

Vancomycin-intermediate Staphylococcus aureus in Korea. J Clin Microbiol (2000) 2.16

Efficacy of cold enrichment techniques for recovery of Yersinia enterocolitica from human stools. J Clin Microbiol (1979) 2.13

Prevalence of enterotoxigenicity in human and nonhuman isolates of Yersinia enterocolitica. Infect Immun (1978) 2.04

Experimental Yersinia enterocolitica enteritis in rabbits. Infect Immun (1980) 1.99

Inhibition of human neutrophil chemiluminescence by plasmid-mediated outer membrane proteins of Yersinia enterocolitica. Infect Immun (1985) 1.72

Invasiveness of Yersinia enterocolitica lacking the virulence plasmid: an in-vivo study. J Med Microbiol (1987) 1.62

Pathogenic properties of Yersinia enterocolitica. Infect Immun (1980) 1.59

Biosynthesis of biotin in microorganisms. VI. Further evidence for desthiobiotin as a precursor in Eschericia coli. J Bacteriol (1967) 1.50

Pseudomembranous colitis in a leukaemia unit: a report of five fatal cases. J Clin Pathol (1979) 1.46

Biosynthesis of biotin in microorganisms. IV. Repression and derepression of (+ -)-biotin synthesis from (+)-desthiobiotin. Arch Biochem Biophys (1966) 1.42

Latex agglutination test for detection of Clostridium difficile toxin in stool samples. J Clin Microbiol (1984) 1.39

Direct estimation of the mutation rate at dinucleotide microsatellite loci in Arabidopsis thaliana (Brassicaceae). Heredity (Edinb) (2009) 1.29

The histopathology of rectosigmoid biopsies from adults with bloody diarrhea due to verotoxin-producing Escherichia coli. Am J Clin Pathol (1987) 1.29

Collagenous colitis and microscopic colitis: the watery diarrhea-colitis syndrome. Am J Gastroenterol (1989) 1.27

Biosynthesis of desthiobiotin in cell-free extracts of Escherichia coli. J Bacteriol (1969) 1.19

Risk factors for Escherichia coli O157:H7 infection in an urban community. J Infect Dis (1989) 1.18

Nosocomial infantile gastroenteritis associated with minirotavirus and calicivirus. J Pediatr (1978) 1.18

Collagenous colitis: a disease of pericryptal fibroblast sheath? J Pathol (1986) 1.17

Biosynthesis of biotin in microorganisms. V. Control of vitamer production. J Bacteriol (1967) 1.17

Prevalence of hepatitis C virus antibody among Korean adults. J Korean Med Sci (1992) 1.12

Enhancement of recovery of Neisseria meningitidis by gelatin in blood culture media. J Clin Microbiol (1981) 1.12

Rapid diagnosis of rotavirus gastroenteritis by a commercial latex agglutination test. J Clin Microbiol (1985) 1.12

Chromosomal location of mutations affecting the regualtion of biotin synthesis in Escherichia coli. Can J Microbiol (1975) 1.11

Mutant of Escherichia coli with derepressed levels of the biotin biosynthetic enzymes. J Bacteriol (1972) 1.10

MR imaging of compressive myelomalacia. J Comput Assist Tomogr (1989) 1.09

Histamine release during antigen inhalation in experimental asthma in dogs. Am Rev Respir Dis (1975) 1.08

Cocaine abuse: neurovascular complications. Radiology (1989) 1.07

Biosynthesis of biotin: synthesis of 7,8-diaminopelargonic acid in cell-free extracts of Escherichia coli. J Bacteriol (1971) 1.06

Spread of multidrug-resistant Streptococcus pneumoniae in South Korea. Clin Infect Dis (1997) 1.05

Chronic right upper quadrant pain without gallstones: does HIDA scan predict outcome after cholecystectomy? Am J Gastroenterol (1990) 1.04

Partial purification and properties of D-desthiobiotin synthetase from Escherichia coli. J Bacteriol (1970) 1.04

The pathogenesis of inflammatory polyps. Dis Colon Rectum (1987) 1.03

Multicenter surveillance study for nosocomial infections in major hospitals in Korea. Nosocomial Infection Surveillance Committee of the Korean Society for Nosocomial Infection Control. Am J Infect Control (2000) 1.03

In vitro susceptibility of Haemophilus influenzae to sulfamethoxazole-trimethoprim and cefaclor, cephalexin, and cephradine. Antimicrob Agents Chemother (1978) 1.02

Yersinia enterocolitica: comparative in vitro activities of seven new beta-lactam antibiotics. Antimicrob Agents Chemother (1982) 0.99

Genetics of biotin biosynthesis in Bacillus subtilis. J Bacteriol (1975) 0.99

Progressive type of focal nodular hyperplasia characterized by multiple tumors and recurrence. Hepatology (1995) 0.98

Fatal Aspergillus pneumonia in chronic granulomatous disease. Am J Clin Pathol (1986) 0.98

Amyloidosis complicating psoriatic arthritis. Br Med J (1977) 0.98

Placebo-controlled double-blind evaluation of trimethoprim-sulfamethoxazole treatment of Yersinia enterocolitica gastroenteritis. J Pediatr (1984) 0.98

Erythromycin in treatment of Campylobacter enteritis in children. Am J Dis Child (1983) 0.97

Reovirus type 3 infection in patients with primary biliary cirrhosis and primary sclerosing cholangitis. J Hepatol (1987) 0.95

Simple screening method for beta-lactamase-positive and -negative ampicillin-resistant Haemophilus influenzae isolates. J Clin Microbiol (1984) 0.94

Biotin uptake in biotin regulatory mutant of Escherichia coli. J Bacteriol (1973) 0.94

Genotype x environment interaction for male attractiveness in an acoustic moth: evidence for plasticity and canalization. J Evol Biol (2006) 0.93

Intestinal metaplasia and dysplasia of prostatic urethra secondary to stricture. Urology (1988) 0.93

Detection of the H1-j strain of Salmonella typhi among Korean isolates by the polymerase chain reaction. Am J Trop Med Hyg (1994) 0.93

The histogenesis of adenocarcinoma of the gallbladder. Cancer (1986) 0.93

Inhibition of thromboxane A2-induced arrhythmias and intracellular calcium changes in cardiac myocytes by blockade of the inositol trisphosphate pathway. J Pharmacol Exp Ther (2009) 0.93

Gastrointestinal function and structure in HIV-positive patients. CMAJ (1990) 0.92

Effect of shock wave therapy on acute fractures of the tibia: a study in a dog model. Clin Orthop Relat Res (2001) 0.91

Model of neonatal meningitis caused by Escherichia coli K1 in guinea pigs. J Infect Dis (1980) 0.90

Giant and symptomatic inflammatory polyps of the colon in idiopathic inflammatory bowel disease. Am J Surg Pathol (1986) 0.89

Changes in airway mast cells and histamine caused by antigen aerosol in allergic dogs. J Appl Physiol Respir Environ Exerc Physiol (1977) 0.89

Assessment of carotid artery invasion in patients with head and neck cancer. Laryngoscope (2000) 0.88

The genetic consequences of fluctuating inbreeding depression and the evolution of plant selfing rates. J Evol Biol (2009) 0.88

Alpha-1-antitrypsin deficiency and hepatocellular carcinoma. J Clin Pathol (1979) 0.88

Serum levels of interleukin-8 in alcoholic liver disease: relationship with disease stage, biochemical parameters and survival. J Hepatol (1996) 0.87

Hepatic and gastric cytoprotective effects of long-term prostaglandin E1 administration in cirrhotic rats. Gastroenterology (1993) 0.87

The local immunological defence system of the human endometrium. J Reprod Immunol (1980) 0.86

Uptake of pimelic acid by Escherichia coli and Pseudomonas denitrificans. Can J Microbiol (1969) 0.85

Short-course doxycycline treatment versus conventional tetracycline therapy for scrub typhus: a multicenter randomized trial. Clin Infect Dis (1995) 0.85

A Bayesian method for the joint estimation of outcrossing rate and inbreeding depression. Heredity (Edinb) (2012) 0.85

Protein-losing enteropathy in systemic lupus erythematosus associated with intestinal lymphangiectasia. Am J Gastroenterol (1990) 0.85

Biochemical and genetic characterization of dehydrobiotin resistant mutants of Escherichia coli. Mol Gen Genet (1974) 0.84

A novel enteropathy with partial villous atrophy, microscopic colitis, and pemphigoid change. J Clin Gastroenterol (1989) 0.84

Alpha-1-antitrypsin Pi S phenotype and liver cell inclusion bodies in alcoholic hepatitis. J Clin Pathol (1979) 0.84

Inflammatory diseases of the gastrointestinal tract. Mod Pathol (1995) 0.84

Pasteurella ureae meningoencephalitis. J Pediatr (1978) 0.83

In situ enzyme immunoassay for antiviral susceptibility testing of respiratory syncytial virus. Am J Clin Pathol (1989) 0.83

The pathology of Q fever hepatitis. A case diagnosed by liver biopsy. J Clin Gastroenterol (1987) 0.83

Orbital pseudotumor: association of orbital vein deformities and myositis. AJNR Am J Neuroradiol (1981) 0.82

Diffuse pneumocephalus from Clostridium perfringens meningitis: CT findings. AJNR Am J Neuroradiol (1989) 0.82

Carcinoid tumors and inflammatory bowel disease. J Surg Oncol (1992) 0.82

Effect of acute Yersinia enterocolitica infection on in vivo and in vitro small intestinal solute and fluid absorption in the rabbit. Gastroenterology (1988) 0.82

The strictures, sinuses, and fissures of Crohn's disease. J Clin Gastroenterol (1986) 0.81

Treatment of candidal diaper dermatitis: a double-blind placebo-controlled comparison of topical nystatin with topical plus oral nystatin. J Pediatr (1982) 0.81

Pilot study of cyclosporin A in patients with symptomatic primary biliary cirrhosis. Gastroenterology (1988) 0.81

Rotavirus gastroenteritis. J Diarrhoeal Dis Res (1990) 0.81

Penetration of the intestinal mucosa by Yersinia enterocolitica lacking the virulence plasmid. Contrib Microbiol Immunol (1987) 0.81

DNA sequences required for yeast actin gene transcription do not include conserved CCAAT motifs. Nucleic Acids Res (1990) 0.80

Indian childhood cirrhosis in the United Kingdom. Gut (1980) 0.79

In vitro activities of quinupristin/dalfopristin and eight other antimicrobial agents against 360 clinical isolates from Korea. Yonsei Med J (2000) 0.78

Genetic markers and inflammatory bowel disease: immunoglobulin allotypes (GM, KM) and protease inhibitor. Am J Gastroenterol (1989) 0.77

The nucleotide sequence, structure, and preliminary studies on the transcriptional regulation of the bovine alpha skeletal actin gene. DNA Cell Biol (1995) 0.77

Inbreeding depression in an asexual population of Mimulus guttatus. J Evol Biol (2009) 0.77

Colonic function in acute Yersinia enterocolitica infection in rabbits. Clin Invest Med (1988) 0.77

Anti-phagocytic role of plasmid-associated outer membrane proteins of Yersinia enterocolitica. Contrib Microbiol Immunol (1987) 0.77